TORCH screening in pregnancy. Where are we now? An audit of use in a tertiary level centre.
This audit was performed in the obstetrics and gynaecology department of a tertiary referral hospital, to investigate the use and results of TORCH screening. St Michael's Hospital delivers approximately 6,000 women from South Bristol a year and receives tertiary referrals from the South West of England and South Wales. It was found that 739 patients over a 6-year period from April 2006 to January 2012 underwent testing. The majority's indication (21%) was polyhydramnios. Three patients had evidence of primary CMV infection in pregnancy on serology, two for fetal indications (polyhydramnios and echogenic bowel) and one following a miscarriage. There were no confirmed cases of gestational toxoplasma or rubella. Routine testing for toxoplasma and rubella infection as part of the TORCH screening in cases of fetal or obstetric abnormality should thus be discontinued in our population.
Department of Obstetrics and Gynaecology.
S
S
Halawa
L
L
McDermott
M
M
Donati
M
M
Denbow
D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000706:statistics & numerical data*; D008485:Medical Audit; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D062606:Tertiary Care Centers / Q000706:statistics & numerical data